Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial
Treatment of adults with autoimmune thrombocytopenic purpura (AITP) is based more on individual experience than on results of controlled studies. Compared intravenous immunoglobulin with high-dose methylprednisolone in untreated adults with severe AITP and assessed efficacy of subsequent oral steroi...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 2002-01, Vol.5, p.23-29 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 29 |
|---|---|
| container_issue | |
| container_start_page | 23 |
| container_title | The Lancet (British edition) |
| container_volume | 5 |
| creator | Godeau, B Chevret, S Varet, B Lefrere, F Zini, J-M Bassompierre, F Cheze, S Legouffre, E Hulin, C Grange, M-J Fain, O Bierling, P |
| description | Treatment of adults with autoimmune thrombocytopenic purpura (AITP) is based more on individual experience than on results of controlled studies. Compared intravenous immunoglobulin with high-dose methylprednisolone in untreated adults with severe AITP and assessed efficacy of subsequent oral steroids compared with placebo. Found that intravenous immunoglobulin and oral prednisone seems to be more effective than high-dose methylprednisolone and oral prednisone in adults with severe AITP, although the latter treatment is effective and well tolerated. (Original abstract - amended) |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_57488766</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>57488766</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_574887663</originalsourceid><addsrcrecordid>eNqNj81OAzEMhHMAifLzDj5x6kpB3WYrrggEd-6Vu3GboCReEqeor8eTkeXnjmRpLPnzjOZMLfRdrzszrMyFuizlTWvdG71eqM-XJBmPlLgW8DHWxIfAuxp8As7g_MF1lgtBJHGnMGWyyRcOnGgJH17cTM3KVdqKAf6QGdi3I9oapPywtYURClkodKRMgFX4O5VAXOa44_EkPFHyI0w1t8F7QMiYLEdfyC4hNjs_0uwEkj2Ga3W-x1Do5lev1O3T4-vDczdlfq9UZNs-RwoBE7WW2_XQbzaDMat_g19s228z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>57488766</pqid></control><display><type>article</type><title>Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial</title><source>Elsevier ScienceDirect Journals Complete</source><source>EBSCOhost Business Source Complete</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>ProQuest Central UK/Ireland</source><creator>Godeau, B ; Chevret, S ; Varet, B ; Lefrere, F ; Zini, J-M ; Bassompierre, F ; Cheze, S ; Legouffre, E ; Hulin, C ; Grange, M-J ; Fain, O ; Bierling, P</creator><creatorcontrib>Godeau, B ; Chevret, S ; Varet, B ; Lefrere, F ; Zini, J-M ; Bassompierre, F ; Cheze, S ; Legouffre, E ; Hulin, C ; Grange, M-J ; Fain, O ; Bierling, P</creatorcontrib><description>Treatment of adults with autoimmune thrombocytopenic purpura (AITP) is based more on individual experience than on results of controlled studies. Compared intravenous immunoglobulin with high-dose methylprednisolone in untreated adults with severe AITP and assessed efficacy of subsequent oral steroids compared with placebo. Found that intravenous immunoglobulin and oral prednisone seems to be more effective than high-dose methylprednisolone and oral prednisone in adults with severe AITP, although the latter treatment is effective and well tolerated. (Original abstract - amended)</description><identifier>ISSN: 0140-6736</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><subject>Drugs ; Idiopathic thrombocytopenic purpura ; Randomized controlled trials ; Treatment</subject><ispartof>The Lancet (British edition), 2002-01, Vol.5, p.23-29</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,31000,64387</link.rule.ids></links><search><creatorcontrib>Godeau, B</creatorcontrib><creatorcontrib>Chevret, S</creatorcontrib><creatorcontrib>Varet, B</creatorcontrib><creatorcontrib>Lefrere, F</creatorcontrib><creatorcontrib>Zini, J-M</creatorcontrib><creatorcontrib>Bassompierre, F</creatorcontrib><creatorcontrib>Cheze, S</creatorcontrib><creatorcontrib>Legouffre, E</creatorcontrib><creatorcontrib>Hulin, C</creatorcontrib><creatorcontrib>Grange, M-J</creatorcontrib><creatorcontrib>Fain, O</creatorcontrib><creatorcontrib>Bierling, P</creatorcontrib><title>Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial</title><title>The Lancet (British edition)</title><description>Treatment of adults with autoimmune thrombocytopenic purpura (AITP) is based more on individual experience than on results of controlled studies. Compared intravenous immunoglobulin with high-dose methylprednisolone in untreated adults with severe AITP and assessed efficacy of subsequent oral steroids compared with placebo. Found that intravenous immunoglobulin and oral prednisone seems to be more effective than high-dose methylprednisolone and oral prednisone in adults with severe AITP, although the latter treatment is effective and well tolerated. (Original abstract - amended)</description><subject>Drugs</subject><subject>Idiopathic thrombocytopenic purpura</subject><subject>Randomized controlled trials</subject><subject>Treatment</subject><issn>0140-6736</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNqNj81OAzEMhHMAifLzDj5x6kpB3WYrrggEd-6Vu3GboCReEqeor8eTkeXnjmRpLPnzjOZMLfRdrzszrMyFuizlTWvdG71eqM-XJBmPlLgW8DHWxIfAuxp8As7g_MF1lgtBJHGnMGWyyRcOnGgJH17cTM3KVdqKAf6QGdi3I9oapPywtYURClkodKRMgFX4O5VAXOa44_EkPFHyI0w1t8F7QMiYLEdfyC4hNjs_0uwEkj2Ga3W-x1Do5lev1O3T4-vDczdlfq9UZNs-RwoBE7WW2_XQbzaDMat_g19s228z</recordid><startdate>20020101</startdate><enddate>20020101</enddate><creator>Godeau, B</creator><creator>Chevret, S</creator><creator>Varet, B</creator><creator>Lefrere, F</creator><creator>Zini, J-M</creator><creator>Bassompierre, F</creator><creator>Cheze, S</creator><creator>Legouffre, E</creator><creator>Hulin, C</creator><creator>Grange, M-J</creator><creator>Fain, O</creator><creator>Bierling, P</creator><scope>7QJ</scope></search><sort><creationdate>20020101</creationdate><title>Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial</title><author>Godeau, B ; Chevret, S ; Varet, B ; Lefrere, F ; Zini, J-M ; Bassompierre, F ; Cheze, S ; Legouffre, E ; Hulin, C ; Grange, M-J ; Fain, O ; Bierling, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_574887663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Drugs</topic><topic>Idiopathic thrombocytopenic purpura</topic><topic>Randomized controlled trials</topic><topic>Treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Godeau, B</creatorcontrib><creatorcontrib>Chevret, S</creatorcontrib><creatorcontrib>Varet, B</creatorcontrib><creatorcontrib>Lefrere, F</creatorcontrib><creatorcontrib>Zini, J-M</creatorcontrib><creatorcontrib>Bassompierre, F</creatorcontrib><creatorcontrib>Cheze, S</creatorcontrib><creatorcontrib>Legouffre, E</creatorcontrib><creatorcontrib>Hulin, C</creatorcontrib><creatorcontrib>Grange, M-J</creatorcontrib><creatorcontrib>Fain, O</creatorcontrib><creatorcontrib>Bierling, P</creatorcontrib><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Godeau, B</au><au>Chevret, S</au><au>Varet, B</au><au>Lefrere, F</au><au>Zini, J-M</au><au>Bassompierre, F</au><au>Cheze, S</au><au>Legouffre, E</au><au>Hulin, C</au><au>Grange, M-J</au><au>Fain, O</au><au>Bierling, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial</atitle><jtitle>The Lancet (British edition)</jtitle><date>2002-01-01</date><risdate>2002</risdate><volume>5</volume><spage>23</spage><epage>29</epage><pages>23-29</pages><issn>0140-6736</issn><coden>LANCAO</coden><abstract>Treatment of adults with autoimmune thrombocytopenic purpura (AITP) is based more on individual experience than on results of controlled studies. Compared intravenous immunoglobulin with high-dose methylprednisolone in untreated adults with severe AITP and assessed efficacy of subsequent oral steroids compared with placebo. Found that intravenous immunoglobulin and oral prednisone seems to be more effective than high-dose methylprednisolone and oral prednisone in adults with severe AITP, although the latter treatment is effective and well tolerated. (Original abstract - amended)</abstract></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 2002-01, Vol.5, p.23-29 |
| issn | 0140-6736 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_57488766 |
| source | Elsevier ScienceDirect Journals Complete; EBSCOhost Business Source Complete; Applied Social Sciences Index & Abstracts (ASSIA); ProQuest Central UK/Ireland |
| subjects | Drugs Idiopathic thrombocytopenic purpura Randomized controlled trials Treatment |
| title | Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T13%3A53%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20immunoglobulin%20or%20high-dose%20methylprednisolone,%20with%20or%20without%20oral%20prednisone,%20for%20adults%20with%20untreated%20severe%20autoimmune%20thrombocytopenic%20purpura:%20a%20randomised,%20multicentre%20trial&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Godeau,%20B&rft.date=2002-01-01&rft.volume=5&rft.spage=23&rft.epage=29&rft.pages=23-29&rft.issn=0140-6736&rft.coden=LANCAO&rft_id=info:doi/&rft_dat=%3Cproquest%3E57488766%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=57488766&rft_id=info:pmid/&rfr_iscdi=true |